1 drug(s) with this reaction
106 total reports
Exposure During Pregnancy has been reported as an adverse reaction across 1 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 106 adverse event reports mention exposure during pregnancy in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with exposure during pregnancy, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have exposure during pregnancy listed in their FDA adverse event reports, sorted by report count:
In addition to exposure during pregnancy, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
1 drug(s) manufactured by Chattem Inc have exposure during pregnancy listed in their FDA adverse event reports: DOXYLAMINE SUCCINATE.
There are a combined 106 reports of exposure during pregnancy across 1 Chattem Inc drug(s) in the FDA adverse event database.